| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
110,353 |
98,510 |
$4.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46,824 |
43,363 |
$2.55M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
27,619 |
15,576 |
$514K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,129 |
8,563 |
$495K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,760 |
7,256 |
$374K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,106 |
4,804 |
$270K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,067 |
3,651 |
$132K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,383 |
3,892 |
$122K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,953 |
1,854 |
$115K |
| 92558 |
|
8,514 |
7,923 |
$87K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,758 |
3,191 |
$82K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,214 |
1,036 |
$71K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,282 |
2,915 |
$53K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,019 |
896 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,966 |
3,643 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
792 |
706 |
$35K |
| 90832 |
Psychotherapy, 30 minutes with patient |
935 |
647 |
$35K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,704 |
3,412 |
$34K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
741 |
614 |
$32K |
| 96127 |
|
6,342 |
4,766 |
$29K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,302 |
2,709 |
$27K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
381 |
357 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
393 |
374 |
$23K |
| 59025 |
Fetal non-stress test |
814 |
576 |
$21K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,921 |
2,591 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
8,658 |
7,782 |
$20K |
| 92587 |
|
904 |
872 |
$16K |
| 99215 |
Prolong outpt/office vis |
264 |
240 |
$16K |
| 99381 |
|
237 |
229 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,069 |
896 |
$13K |
| 90834 |
Psychotherapy, 45 minutes with patient |
255 |
185 |
$13K |
| D1208 |
Topical application of fluoride, excluding varnish |
979 |
914 |
$11K |
| 92552 |
|
836 |
804 |
$9K |
| 90686 |
|
4,370 |
4,158 |
$7K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
12 |
12 |
$7K |
| 90670 |
|
4,734 |
4,495 |
$7K |
| 76801 |
|
103 |
90 |
$7K |
| 99173 |
|
2,171 |
2,020 |
$5K |
| 99442 |
|
230 |
209 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
347 |
333 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
53 |
48 |
$4K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
126 |
122 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
854 |
803 |
$4K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
67 |
66 |
$3K |
| 87807 |
|
302 |
274 |
$3K |
| 90633 |
|
2,243 |
2,139 |
$2K |
| 90710 |
|
1,889 |
1,795 |
$2K |
| 90474 |
|
268 |
262 |
$2K |
| 76830 |
Ultrasound, transvaginal |
25 |
24 |
$2K |
| 87210 |
|
357 |
311 |
$1K |
| 90671 |
|
757 |
637 |
$1K |
| 99307 |
|
204 |
181 |
$1K |
| 99177 |
|
249 |
243 |
$962.13 |
| 81025 |
|
196 |
159 |
$957.98 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
13 |
$901.69 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
15 |
12 |
$864.72 |
| H1000 |
Prenatal care, at-risk assessment |
12 |
12 |
$852.61 |
| 99306 |
Prolong nursin fac eval 15m |
55 |
50 |
$837.83 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
77 |
74 |
$813.38 |
| 90723 |
|
4,075 |
3,821 |
$582.97 |
| 97802 |
|
12 |
12 |
$575.62 |
| 90647 |
|
3,808 |
3,576 |
$526.51 |
| 90473 |
|
38 |
38 |
$445.09 |
| 99441 |
|
34 |
34 |
$382.88 |
| 81002 |
|
205 |
183 |
$366.02 |
| 99188 |
|
37 |
36 |
$348.60 |
| 90677 |
|
310 |
302 |
$299.72 |
| 90734 |
|
437 |
427 |
$284.81 |
| 0124A |
|
12 |
12 |
$279.57 |
| 90656 |
|
226 |
220 |
$277.70 |
| 90681 |
|
1,698 |
1,611 |
$159.86 |
| 81003 |
|
120 |
108 |
$126.91 |
| 90651 |
|
338 |
329 |
$70.12 |
| G0008 |
Administration of influenza virus vaccine |
14 |
13 |
$27.95 |
| 90715 |
|
86 |
84 |
$20.37 |
| 90672 |
|
146 |
143 |
$20.33 |
| 82962 |
|
13 |
13 |
$18.66 |
| 90700 |
|
332 |
321 |
$10.81 |
| 90696 |
|
121 |
115 |
$10.67 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
85 |
81 |
$3.18 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
32 |
32 |
$1.24 |
| 91307 |
|
44 |
41 |
$0.27 |
| 90685 |
|
78 |
74 |
$0.03 |
| 91312 |
|
12 |
12 |
$0.03 |
| 3074F |
|
1,871 |
1,761 |
$0.02 |
| 3078F |
|
1,514 |
1,428 |
$0.02 |
| 3079F |
|
635 |
605 |
$0.00 |
| 3075F |
|
213 |
205 |
$0.00 |
| 3080F |
|
121 |
118 |
$0.00 |
| 0503F |
|
284 |
220 |
$0.00 |
| 3077F |
|
184 |
177 |
$0.00 |
| 90461 |
|
13 |
13 |
$0.00 |